Global Retirement Partners LLC Sells 46 Shares of Becton, Dickinson and Company (NYSE:BDX)

Global Retirement Partners LLC trimmed its holdings in Becton, Dickinson and Company (NYSE:BDXFree Report) by 2.2% in the 4th quarter, Holdings Channel reports. The fund owned 2,015 shares of the medical instruments supplier’s stock after selling 46 shares during the quarter. Global Retirement Partners LLC’s holdings in Becton, Dickinson and Company were worth $473,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds also recently modified their holdings of BDX. Moneta Group Investment Advisors LLC boosted its position in shares of Becton, Dickinson and Company by 95,813.8% in the fourth quarter. Moneta Group Investment Advisors LLC now owns 4,045,643 shares of the medical instruments supplier’s stock valued at $1,028,807,000 after acquiring an additional 4,041,425 shares during the period. Norges Bank bought a new stake in shares of Becton, Dickinson and Company in the fourth quarter valued at approximately $697,398,000. Ontario Teachers Pension Plan Board boosted its position in shares of Becton, Dickinson and Company by 242.8% in the third quarter. Ontario Teachers Pension Plan Board now owns 1,783,769 shares of the medical instruments supplier’s stock valued at $461,158,000 after acquiring an additional 1,263,391 shares during the period. PineStone Asset Management Inc. boosted its position in shares of Becton, Dickinson and Company by 262.0% in the third quarter. PineStone Asset Management Inc. now owns 847,448 shares of the medical instruments supplier’s stock valued at $219,091,000 after acquiring an additional 613,369 shares during the period. Finally, Marshall Wace LLP boosted its position in shares of Becton, Dickinson and Company by 86.6% in the second quarter. Marshall Wace LLP now owns 1,196,061 shares of the medical instruments supplier’s stock valued at $315,772,000 after acquiring an additional 555,090 shares during the period. 86.97% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

A number of brokerages recently commented on BDX. Barclays upped their target price on Becton, Dickinson and Company from $301.00 to $305.00 and gave the company an “overweight” rating in a research note on Monday, February 5th. Morgan Stanley cut their target price on Becton, Dickinson and Company from $310.00 to $280.00 and set an “overweight” rating for the company in a research note on Monday, December 4th. Finally, Raymond James upped their target price on Becton, Dickinson and Company from $269.00 to $275.00 and gave the company an “outperform” rating in a research note on Wednesday, January 3rd. Two research analysts have rated the stock with a hold rating and five have issued a buy rating to the company. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $279.17.

Get Our Latest Stock Analysis on Becton, Dickinson and Company

Insider Activity

In other news, SVP Thomas J. Spoerel sold 282 shares of the firm’s stock in a transaction on Thursday, March 14th. The stock was sold at an average price of $238.29, for a total value of $67,197.78. Following the completion of the sale, the senior vice president now directly owns 2,276 shares in the company, valued at $542,348.04. The sale was disclosed in a filing with the SEC, which is accessible through this link. 0.31% of the stock is currently owned by corporate insiders.

Becton, Dickinson and Company Stock Performance

Becton, Dickinson and Company stock opened at $244.04 on Tuesday. The company has a debt-to-equity ratio of 0.56, a current ratio of 1.08 and a quick ratio of 0.64. The stock has a fifty day moving average price of $239.68 and a two-hundred day moving average price of $244.66. Becton, Dickinson and Company has a 52-week low of $229.85 and a 52-week high of $287.32. The firm has a market capitalization of $70.50 billion, a P/E ratio of 57.83, a P/E/G ratio of 2.04 and a beta of 0.43.

Becton, Dickinson and Company (NYSE:BDXGet Free Report) last released its quarterly earnings data on Thursday, February 1st. The medical instruments supplier reported $2.68 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.39 by $0.29. Becton, Dickinson and Company had a return on equity of 13.57% and a net margin of 6.44%. The firm had revenue of $4.71 billion during the quarter, compared to analyst estimates of $4.73 billion. During the same period in the prior year, the company posted $2.98 earnings per share. The business’s revenue for the quarter was up 2.6% compared to the same quarter last year. As a group, analysts anticipate that Becton, Dickinson and Company will post 12.94 EPS for the current fiscal year.

Becton, Dickinson and Company Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, March 29th. Stockholders of record on Friday, March 8th were paid a $0.95 dividend. The ex-dividend date of this dividend was Thursday, March 7th. This represents a $3.80 dividend on an annualized basis and a dividend yield of 1.56%. Becton, Dickinson and Company’s dividend payout ratio (DPR) is presently 90.05%.

Becton, Dickinson and Company Profile

(Free Report)

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company operates in three segments: BD Medical, BD Life Sciences, and BD Interventional.

Recommended Stories

Want to see what other hedge funds are holding BDX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Becton, Dickinson and Company (NYSE:BDXFree Report).

Institutional Ownership by Quarter for Becton, Dickinson and Company (NYSE:BDX)

Receive News & Ratings for Becton Dickinson and Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Becton Dickinson and Company and related companies with MarketBeat.com's FREE daily email newsletter.